Vanessa Arfi
Impact in
- Virology top 5%
- HIV Research and Treatment
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
- interferon and immune responses
Papers in
- Virology 3
- HIV Research and Treatment 3
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Alain PuisieuxIsabelle TreilleuxSophie Goddard‐LéonDaniel OliveThomas BachelotNathalie Bendriss‐VermareIsabelle Ray‐CoquardChristelle Fauré
- Journals
- Journal of Virology (3 papers)PLoS Genetics (2 papers)Cancer Research (2 papers)Cell Death and Disease (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Vanessa Arfi
8 papers receiving 944 citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Virology 200
- Immunology 592
- Oncology 433
- Infectious Diseases 85
- Cancer Research 54
Countries citing papers authored by Vanessa Arfi
This map shows the geographic impact of Vanessa Arfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Arfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Arfi more than expected).
Fields of papers citing papers by Vanessa Arfi
This network shows the impact of papers produced by Vanessa Arfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Arfi. The network helps show where Vanessa Arfi may publish in the future.
Co-authors
The 25 scholars most cited alongside Vanessa Arfi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 31 | |
| 2 | 2013 | 22 | |
| 3 | Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome Hit paper breakdown → | 2009 | 562 |
| 4 | 2009 | 13 | |
| 5 | 2009 | 95 | |
| 6 | 2009 | 48 | |
| 7 | 2008 | 115 | |
| 8 | 2008 | 65 |
About Vanessa Arfi
Vanessa Arfi is a scholar working on Virology, Infectious Diseases, Immunology, Biotechnology and Oncology, having authored 8 papers that have together received 951 indexed citations. Recurring topics across this work include HIV Research and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), HIV/AIDS drug development and treatment (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), Signaling Pathways in Disease (1 paper), TGF-β signaling in diseases (1 paper), Glutathione Transferases and Polymorphisms (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Virology (200 citations), Immunology (592 citations), Oncology (433 citations), Infectious Diseases (85 citations) and Cancer Research (54 citations). Vanessa Arfi has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Alain Puisieux, Isabelle Treilleux, Sophie Goddard‐Léon, Daniel Olive, Thomas Bachelot, Nathalie Bendriss‐Vermare, Isabelle Ray‐Coquard, Christelle Fauré, Christophe Caux and Michael Gobert. Their work appears in journals such as Journal of Virology, PLoS Genetics, Cancer Research and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.